Eric Topol on Nostr: Paxlovid didn’t provide any benefit in a placebo-controlled randomized trial in ...
Published at
2024-04-03 21:42:25Event JSON
{
"id": "4bbc72f006839f8be57784440841dca31744f202a539a23f1517819ceaed91ee",
"pubkey": "5077f486a3f2f72d07e0efd5cb00aa243734739327371edd92d5c63a7b7dfe53",
"created_at": 1712180545,
"kind": 1,
"tags": [
[
"proxy",
"https://mstdn.social/users/erictopol/statuses/112209464241767049",
"activitypub"
]
],
"content": "Paxlovid didn’t provide any benefit in a placebo-controlled randomized trial in lower risk (mean age 42 years) outpatients with mild-to-moderate Covid \n\nhttps://www.nejm.org/doi/full/10.1056/NEJMoa2309003\n\nhttps://media.mstdn.social/media_attachments/files/112/209/463/975/745/403/original/331df327e5d9cddd.png",
"sig": "aca85f913a9012a417c08034003b72f48006eff3123ca19d3aa381b3866a9e0645ffc8ae30ba4f5e8fb9b5a11a38dcbb459121bb37edfda53a3c7a176469f799"
}
